Long-Term Management of Generalised Anxiety Disorder with Low-Dose Continuous Infusions of Flumazenil: A Case Series
Background: Generalised anxiety disorder (GAD) is a common anxiety disorder associated with social and occupational impairment. Recently, a theory was postulated that dysfunctional gamma aminobutyric acid type A receptors (GABA<sub>A</sub>) are implicated in anxiety symptomology, which c...
Main Authors: | Alexander T. Gallo, Stephen Addis, Vlad Martyn, Hishani Ramanathan, Grace K. Wilkerson, Sean D. Hood, Hans Stampfer, Gary K. Hulse |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Behavioral Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-328X/12/11/430 |
Similar Items
-
Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?
by: Alexander Gallo, et al.
Published: (2022-10-01) -
The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance
by: Alexander T Gallo, et al.
Published: (2023-03-01) -
Continuous Infusion of Flumazenil in the Management of Benzodiazepines Detoxification
by: Anna Benini, et al.
Published: (2021-03-01) -
Efecto antagonista del flumazenil sobre el isoflurano en la emersión de la anestesia general
by: Javier Eduardo Moreno Sánchez, et al.
Published: (2020-03-01) -
Efecto antagonista del flumazenil sobre el isoflurano en la emersión de la anestesia general
by: Jonathan De Freitas H., et al.
Published: (2020-09-01)